Static Chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 1.110 USD | +6.73% |
|
+7.77% | -33.53% |
| 10-29 | Lineage Cell Therapeutics Provides Update On ReSonance Program For Hearing Loss | CI |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
Select your edition
All financial news and data tailored to specific country editions
















